Clinical Trial Update: Ketamine and Midazolam Infusions for CRPS: Feasibility Study [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating ketamine and midazolam infusions for complex regional pain syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• Ketamine (ketamine)
• Midazolam (Midazolam)

Snippet

Sponsor: Stanford University | Conditions: Complex Regional Pain Syndromes | Phase 2 | Status: WITHDRAWN